Detalhe da pesquisa
1.
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
N Engl J Med
; 390(9): 783-794, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381664
2.
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
N Engl J Med
; 390(9): 795-805, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962077
3.
Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts.
Gastroenterology
; 166(6): 995-1019, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342195
4.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386786
5.
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
J Hepatol
; 79(3): 853-866, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37164270
6.
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.
J Hepatol
; 76(4): 841-849, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066089
7.
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
J Hepatol
; 77(2): 353-364, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367282
8.
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
J Hepatol
; 74(6): 1344-1354, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33484775
9.
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
N Engl J Med
; 378(4): 354-369, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365309
10.
Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis.
Clin Gastroenterol Hepatol
; 19(6): 1248-1257, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32707342
11.
Presentation and Outcomes of Autoimmune Hepatitis Type 1 and Type 2 in Children: A Single-center Study.
J Pediatr Gastroenterol Nutr
; 72(1): 101-107, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796427
12.
Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic.
Am J Transplant
; 20(11): 3113-3122, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524743
13.
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
N Engl J Med
; 376(22): 2134-2146, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28564569
14.
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development.
J Autoimmun
; 114: 102514, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32768244
15.
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials.
J Viral Hepat
; 27(11): 1222-1233, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594612
16.
The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough!
Hepatology
; 79(3): 529-531, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722131
17.
A learning curve in using orphan liver allografts for transplantation.
Clin Transplant
; 34(4): e13821, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034946
18.
Aggressive utilization of liver allografts: Improved outcomes over time.
Clin Transplant
; 34(7): e13860, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32198898
19.
Pediatric length-of-stay index following liver transplantation.
Pediatr Transplant
; 24(7): e13779, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720748
20.
No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades.
Ann Surg
; 269(1): 20-27, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29303806